Immunic AG | WebDisclosure

Basculer en Français

8225	Companies
111012	Keywords
52741	Articles
60929	Press releases

Home
Companies
Immunic AG

BRIEF

published on 11/07/2024 at 12:35, 22 hours 48 minutes ago

Immunic, Inc. publie ses résultats financiers du troisième trimestre 2024

Résultats Financiers Vidofludimus Calcique Essais ENSURE De Phase 3 Recherche Sur La Sclérose En Plaques Mises À Jour Des Essais Cliniques
BRIEF

published on 11/07/2024 at 12:35, 22 hours 48 minutes ago

Immunic, Inc. Reports Q3 2024 Financial Results

Financial Results Vidofludimus Calcium Phase 3 ENSURE Trials Multiple Sclerosis Research Clinical Trial Updates
PRESS RELEASE

published on 11/07/2024 at 12:30, 22 hours 53 minutes ago

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2024 financial results, positive Phase 3 ENSURE Program interim analysis. Twin Phase 3 ENSURE trials and Phase 2 CALLIPER trial on track. Webcast held on Nov 7. IMUX stock update

Financial Results Immunic Inc. Q3 2024 Phase 3 ENSURE Program IMUX Stock
BRIEF

published on 10/31/2024 at 11:35, 7 days 23 hours ago

Immunic, Inc. publiera ses résultats financiers du troisième trimestre 2024 et une mise à jour de l'entreprise

Résultats Financiers Biotechnologie Webcast Essais Cliniques Immunique
BRIEF

published on 10/31/2024 at 11:35, 7 days 23 hours ago

Immunic, Inc. to Release Q3 2024 Financial Results and Corporate Update

Financial Results Biotechnology Clinical Trials Webcast Immunic
PRESS RELEASE

published on 10/31/2024 at 11:30, 7 days 23 hours ago

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Immunic, Inc. (Nasdaq: IMUX) to release Q3 financial results and corporate update on Nov 7, 2024. Webcast at 8:00 am ET. Company developing therapies for inflammatory and autoimmune diseases. Visit www.imux.com for more info

Financial Results Biotechnology Corporate Update Immunic Inc. Clinical Pipeline
BRIEF

published on 10/29/2024 at 11:35, 9 days 23 hours ago

Immunic participera à des conférences clés tout au long du mois de novembre

Biotechnologie Conférences Investisseurs Essais Cliniques Immunique
BRIEF

published on 10/29/2024 at 11:35, 9 days 23 hours ago

Immunic to Participate in Key Conferences Throughout November

Investors Biotechnology Clinical Trials Conférences Immunic
PRESS RELEASE

published on 10/29/2024 at 11:30, 9 days 23 hours ago

Immunic to Participate in Industry, Scientific and Investor Conferences in November
Immunic to participate in industry, scientific, and investor conferences in November 2024, presenting data on IMU-856 for celiac disease. Details on events and presentations available on company website

Clinical Trials Conférences Investor Immunic Scientific
BRIEF

published on 10/22/2024 at 12:35, 16 days 22 hours ago

Immunic Reports Positive Interim Results for Phase 3 ENSURE Program

Biotechnology Vidofludimus Calcium Phase 3 Trials Relapsing Multiple Sclerosis Interim Analysis

1 2 ... 6

Accesswire

Published on 11/08/2024 at 10:00, 1 hour 23 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 2 hours 23 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 4 hours 23 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 8 hours 23 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 9 hours 58 minutes ago

PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 11:12, 11 minutes ago

Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 13 minutes ago

Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure
Published on 11/08/2024 at 11:06, 17 minutes ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/08/2024 at 11:00, 23 minutes ago

BluSky Carbon CEO Presents a Case for ClimateTech Optimism
Published on 11/08/2024 at 10:45, 38 minutes ago

SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR

Les Echos

Published on 11/08/2024 at 08:00, 3 hours 23 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 16 hours 23 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 16 hours 23 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 23 minutes ago

ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 23 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE